Cargando…
Heparanase: A Novel Therapeutic Target for the Treatment of Atherosclerosis
Cardiovascular disease (CVD) is the leading cause of death and disability worldwide, and its management places a huge burden on healthcare systems through hospitalisation and treatment. Atherosclerosis is a chronic inflammatory disease of the arterial wall resulting in the formation of lipid-rich, f...
Autores principales: | Nguyen, Tien K., Paone, Stephanie, Chan, Enoch, Poon, Ivan K. H., Baxter, Amy A., Thomas, Shane R., Hulett, Mark D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599978/ https://www.ncbi.nlm.nih.gov/pubmed/36291066 http://dx.doi.org/10.3390/cells11203198 |
Ejemplares similares
-
The Heparanase Regulatory Network in Health and Disease
por: Mayfosh, Alyce J., et al.
Publicado: (2021) -
Heparanase and the hallmarks of cancer
por: Jayatilleke, Krishnath M., et al.
Publicado: (2020) -
Soluble Heparan Sulfate Fragments Generated by Heparanase Trigger the Release of Pro-Inflammatory Cytokines through TLR-4
por: Goodall, Katharine J., et al.
Publicado: (2014) -
The lure of the lipids: how defensins exploit membrane phospholipids to induce cytolysis in target cells
por: Baxter, Amy A, et al.
Publicado: (2017) -
Leukocyte Heparanase: A Double-Edged Sword in Tumor Progression
por: Mayfosh, Alyce J., et al.
Publicado: (2019)